Home Tags CGN

Tag: CGN

Cognetivity Neurosciences Selected to Present New Landmark Research Data at the...

Cognetivity to present new, validated data demonstrating strong correleation with its ICA software test results and blood biomarkers associated with neurodegeneration. VANCOUVER, March 27, 2019 /CNW/ -...

Cognetivity Neurosciences Closes First Tranche of Non-Brokered Private Placement

VANCOUVER, March 19, 2019 /CNW/ - Cognetivity Neurosciences Ltd. (the "Company" or "Cognetivity") (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) announces that pursuant to its news releases dated February...

Cognetivity Neurosciences Secures Critical Quality Standard Certification

ISO 13485 certification for medical device development a critical prerequisite for global regulatory applications Certification confirms Cognetivity's internal quality systems comply with international standards...

Cognetivity Neurosciences Announces Non-Brokered Private Placement

VANCOUVER, Feb. 11, 2019 /CNW/ - Cognetivity Neurosciences Ltd. (the "Company" or "Cognetivity") (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) announces that it plans to raise up to $2,500,000 by...

Cognetivity Publishes Key Results From Research in Nature’s Scientific Reports Journal

Groundbreaking results published in leading peer-reviewed scientific journal Important academic validation of underlying science behind Cognetivity's cognitive assessment platform VANCOUVER, Jan. 31, 2019 /CNW/ - Cognetivity Neurosciences...

Cognetivity Neurosciences Announced as 9th Industry Partner for Dementias Platform UK

Cognetivity joins eight other select industry companies including AstraZeneca, GlaxoSmithKline and Janssen, and ten leading academic institutions including University of Oxford, University of Cambridge and Imperial...

Cognetivity Neurosciences Named as Young Company to Watch in 2019 on...

Company named as one of five young companies making an impact on the world to watch in 2019 Enormous potential of company's technology...

Cognetivity Neurosciences’ Executive Selected to Speak at Genesis Life Science &...

VANCOUVER, Dec. 12, 2018 /CNW/ - Cognetivity Neurosciences Ltd. (the "Company" or "Cognetivity") (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today announced that Chief Operations Officer, Dr. Tom Sawyer,...

Editors Picks

Get the best financial news straight into your inbox!